Prognostic significance of the preoperative hemoglobin to albumin ratio for the short-term survival of gastric cancer patients

Table 3 Comparison of the relevant factors between the high hemoglobin to albumin ratio group and low hemoglobin to albumin ratio group

Factors	High HAR group (n = 158)	Low HAR group (n = 154)	P value
Age (yr)	61 (53-67)	63 (54-69)	0.266
Sex (n)			0.000
Male	132	93
Female	26	61
BMI (kg/m2)	21.81 (19.90-23.82)	21.30 (19.32-23.33)	0.154
Smoking (n)			0.468
Yes	35	29
No	123	125
Drinking (n)			0.322
Yes	28	21
No	130	133
CEA (ng/mL)	2.89 (1.87-5.23)	2.97 (1.83-5.44)	0.581
CA19-9 (U/mL)	12.63 (7.43-21.52)	13.38 (7.23-24.20)	0.658
CA125 (U/mL)	8.30 (5.68-11.30)	9.15 (6.08-16.80)	0.034
CA72-4 (IU/mL)	1.91 (1.19-4.46)	1.73 (1.14-4.46)	0.396
PHR	1.55 (1.25-1.95)	2.29 (1.71-3.36)	0.000
PLR	138.71 (98.29-188.22)	177.27 (134.34-252.12)	0.000
PAR	5.49 (4.36-6.86)	6.04 (4.70-8.20)	0.002
FLR	1.83 (1.39-2.62)	2.26 (1.57-3.11)	0.001
AFR	13.73 (10.92-16.83)	12.62 (9.69-16.93)	0.162
HFR	48.46 ± 14.63	36.42 ± 18.78	0.000
PFR	73.48 (57.12-92.62)	79.78 (60.16-112.23)	0.040
NLR	2.32 (1.74-3.36)	2.89 (1.92-3.78)	0.024
ALR	24.40 (19.05-32.52)	27.87 (23.08-35.77)	0.000
Tumor size (cm)	3.5 (2.4-5.0)	4.5 (3.0-6.1)	0.009
Vascular infiltration (n)			0.507
present	88	80
absent	70	74
Nerve infiltration (n)			0.918
present	75	74
absent	83	80
Histological grade (n)			0.682
G1	3	3
G2	59	61
G3	96	90
Stage (n)			0.036
Ⅰ	56	32
Ⅱ	32	43
Ⅲ	70	79
T classification (n)			0.037
T1	44	27
T2	18	17
T3	20	21
T4	76	89
N classification (n)			0.141
N0	79	63
N1	14	13
N2	25	34
N3	40	44

HAR: Hemoglobin to albumin ratio; BMI: Body mass index; PHR: Platelet to hemoglobin ratio; PLR: Platelet to lymphocyte ratio; PAR: Platelet to albumin ratio; FLR: Fibrinogen to lymphocyte ratio; AFR: Albumin to fibrinogen ratio; HFR: Hemoglobin to fibrinogen ratio; PFR: Platelet to fibrinogen ratio; NLR: Neutrophil to lymphocyte ratio; ALR: Albumin to lymphocyte ratio.